| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.49 | 0.09 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.3 | 0.09 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |